| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.75B | 2.36B | 2.16B | 1.85B | 1.47B |
| Gross Profit | 2.05B | 1.69B | 1.55B | 1.35B | 1.06B |
| EBITDA | 730.82M | 461.96M | 488.21M | 532.94M | 407.25M |
| Net Income | 714.14M | 525.71M | 487.71M | 427.39M | 380.00M |
Balance Sheet | |||||
| Total Assets | 7.34B | 5.91B | 4.80B | 3.82B | 3.05B |
| Cash, Cash Equivalents and Short-Term Investments | 5.15B | 4.03B | 3.10B | 2.38B | 1.66B |
| Total Debt | 75.78M | 55.77M | 60.98M | 54.59M | 63.12M |
| Total Liabilities | 1.51B | 1.27B | 1.09B | 904.83M | 779.75M |
| Stockholders Equity | 5.83B | 4.64B | 3.72B | 2.91B | 2.27B |
Cash Flow | |||||
| Free Cash Flow | 1.07B | 885.14M | 766.96M | 750.25M | 542.56M |
| Operating Cash Flow | 1.09B | 911.34M | 780.47M | 764.46M | 551.25M |
| Investing Cash Flow | -700.14M | -1.08B | -1.01B | -346.15M | -333.63M |
| Financing Cash Flow | 26.11M | -16.19M | -19.38M | -4.14M | 33.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $8.82B | 62.00 | 6.78% | ― | 15.45% | 37.72% | |
74 Outperform | $36.54B | 16.59 | 24.22% | 0.18% | 3.52% | 32.21% | |
72 Outperform | $9.62B | 40.74 | 24.61% | ― | 20.21% | 44.14% | |
67 Neutral | $5.78B | 53.47 | 4.25% | ― | 17.23% | ― | |
66 Neutral | $39.52B | 46.72 | 13.72% | ― | 15.96% | 27.91% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | $13.16B | ― | -72.61% | ― | 72.58% | 76.81% |
Veeva Systems Inc. recently held its earnings call, presenting a balanced view of its performance. The company showcased robust revenue growth and innovation, particularly in AI and Crossix, while also addressing challenges in customer retention within the CRM segment and potential revenue risks from customer migrations.
Veeva Systems Inc. is a leading provider of cloud-based solutions tailored for the global life sciences industry, offering software, data, and consulting services to enhance productivity and customer engagement. In its fiscal 2026 third quarter, Veeva Systems reported strong financial results with total revenues reaching $811.2 million, marking a 16% increase from the previous year. Subscription services, a major revenue driver, rose by 17% to $682.5 million. The company also highlighted significant advancements in its AI initiatives, aiming to transform productivity within the life sciences sector.
On November 17, 2025, Veeva Systems Inc. announced that Kristine Diamond, the Chief Accounting Officer, will resign from her position effective December 11, 2025. Following her departure, Brian Van Wagener, the Chief Financial Officer, will temporarily assume the role of principal accounting officer until a successor is appointed.
The most recent analyst rating on (VEEV) stock is a Buy with a $321.93 price target. To see the full list of analyst forecasts on Veeva Systems stock, see the VEEV Stock Forecast page.
Veeva Systems Inc. recently held an earnings call that conveyed a generally positive sentiment, underscored by strong financial performance and strategic advancements. The company highlighted significant progress, particularly with the resolution of the IQVIA lawsuit and advancements in AI development. While challenges such as resistance to certain products and flat growth in one segment were noted, the overall outlook remains optimistic due to these positive developments and future potential.
Veeva Systems Inc., a prominent provider of cloud-based solutions for the life sciences industry, has reported its fiscal 2026 second-quarter earnings, showcasing significant growth in revenue and profitability.